Antibodies, Anti-Idiotypic
"Antibodies, Anti-Idiotypic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies.
Descriptor ID |
D000888
|
MeSH Number(s) |
D12.776.124.486.485.114.071 D12.776.124.790.651.114.071 D12.776.377.715.548.114.071
|
Concept/Terms |
Antibodies, Anti-Idiotypic- Antibodies, Anti-Idiotypic
- Anti-Idiotypic Antibodies
- Antibodies, Anti Idiotypic
- Anti-Idiotype Antibodies
- Anti Idiotype Antibodies
- Antibodies, Anti-Idiotype
Anti-Antibodies- Anti-Antibodies
- Antiglobulins
- Antigamma Globulin Antibodies
- Antibodies, Antigamma Globulin
- Globulin Antibodies, Antigamma
- Anti Antibodies
- Antibodies, Anti
- Anti-gamma Globulin Antibodies
- Anti gamma Globulin Antibodies
- Antibodies, Anti-gamma Globulin
- Globulin Antibodies, Anti-gamma
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Anti-Idiotypic".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Anti-Idiotypic".
This graph shows the total number of publications written about "Antibodies, Anti-Idiotypic" by people in this website by year, and whether "Antibodies, Anti-Idiotypic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 0 | 2 |
1996 | 1 | 0 | 1 |
2007 | 1 | 1 | 2 |
2008 | 0 | 1 | 1 |
2009 | 0 | 2 | 2 |
2012 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibodies, Anti-Idiotypic" by people in Profiles.
-
Anti-Ro and Concomitant Anti-La Autoantibodies Strongly Associated With Anti-oxLDL or Anti-Phospholipid Antibody in Systemic Lupus Erythematosus. J Clin Rheumatol. 2016 Dec; 22(8):418-425.
-
Invisible Ink Marking in ECL Membrane Assays. Methods Mol Biol. 2015; 1314:375-82.
-
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012 Aug; 64(8):2677-86.
-
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus. Arthritis Rheum. 2009 Sep 15; 61(9):1168-78.
-
Novel evidence-based systemic lupus erythematosus responder index. Arthritis Rheum. 2009 Sep 15; 61(9):1143-51.
-
Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J Exp Med. 2009 Jan 16; 206(1):139-51.
-
An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb. Clin Exp Allergy. 2008 Feb; 38(2):313-9.
-
Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial. Arthritis Rheum. 2007 Dec; 56(12):4142-50.
-
Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch. J Heart Lung Transplant. 2007 Nov; 26(11):1163-9.
-
The production and characterisation of a chimaeric human IgE antibody, recognising the major mite allergen Der p 1, and its chimaeric human IgG1 anti-idiotype. Mol Pathol. 2002 Oct; 55(5):315-24.